Oxidronic acid
- Generic Name
- Oxidronic acid
- Drug Type
- Small Molecule
- Chemical Formula
- CH6O7P2
- CAS Number
- 15468-10-7
- Unique Ingredient Identifier
- 71MR4V32TI
Overview
No overview information available.
Background
No background information available.
Indication
Oxidronic acid is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients.
Associated Conditions
- Osteogenesis Imperfecta (OI)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|---|---|---|---|---|
INJECTION, POWDER, FOR SOLUTION | 3.15 mg/vial | 1999/02/08 | SIN10712P | ||
INJECTION, POWDER, FOR SOLUTION | 3 mg/vial | 2002/12/23 | SIN12151P |
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No NMPA products found
No NMPA products found for this drug
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|---|---|---|---|---|
160732 | Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific | Active | 2011/08/15 | sodium oxidronate | |
75500 | Active | 2000/08/02 | sodium oxidronate |
© Copyright 2025. All Rights Reserved by MedPath